In our research on adult women with PCOS, the patients exhibited unique genetic expressions (upregulation of FTO and INSR and downregulation of Nrf2), along with specific metabolic, inflammatory, and anthropometric markers that make them more susceptible to the advancement of the condition. This evidence concerns the gene FTO and polycystic ovary syndrome.